BioCentury
ARTICLE | Emerging Company Profile

Vascular Therapeutics Inc.

September 21, 1998 7:00 AM UTC

Mountain View, Calif

Technology: Understanding at the molecular level of the mechanisms responsible for excessive blood clotting...